COVID-19 pandemic impact on severe asthma patients care in Europe

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON24123

Enrollment

900

Registered

2020-11-18

Start date

2020-11-22

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe asthma

Interventions

Online or paper version survey

Eligibility

Inclusion criteria

Inclusion criteria: patients with physician diagnosed severe asthma who are followed up in an asthma clinic for at least 6 months at the beginning of the COVID-19 pandemic

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Description of changes in severe asthma care.	—

Secondary

Measure	Time frame
Description of changes in asthma control of severe asthma patients as a consequence of changes in severe asthma care.	—

Contacts

Public ContactKatrien Eger

Amsterdam University Medical Center

k.a.eger@amsterdamumc.nl0205667924

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)